Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

被引：30

作者：

Lambertini, Matteo ^{[1
,2
]}

Blondeaux, Eva ^{[1
]}

Perrone, Francesco ^{[3
]}

Del Mastro, Lucia ^{[1
,2
]}

机构：

[1] IRCCS Osped Policlin San Martino, Genoa, Italy

[2] Univ Genoa, Genoa, Italy

[3] IRCCS Fdn G Pascale, Ist Nazl Tumori, Naples, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 12期

关键词：

OVARIAN-FUNCTION SUPPRESSION; INTERNATIONAL CONSENSUS GUIDELINES; PATIENT-REPORTED OUTCOMES; PLUS ZOLEDRONIC ACID; QUALITY-OF-LIFE; CLINICAL-PRACTICE; YOUNG-WOMEN; ITALIAN ASSOCIATION; FERTILITY CONCERNS; AMERICAN SOCIETY;

D O I：

10.1200/JCO.19.02242

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.

引用

页码：1258 / +

页数：11

共 70 条

[51] Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Partridge, Ann H.
Hughes, Melissa E.
Warner, Erica T.
Ottesen, Rebecca A.
Wong, Yu-Ning
Edge, Stephen B.
Theriault, Richard L.
Blayney, Douglas W.
Niland, Joyce C.
Winer, Eric P.
Weeks, Jane C.
Tamimi, Rulla M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (27) : 3308 - +
[52] Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial
Perrone, Francesco
De Laurentiis, Michelino
De Placido, Sabino
Orditura, Michele
Cinieri, Saverio
Riccardi, Ferdinando
Ribecco, Angela Stefania
Putzu, Carlo
Del Mastro, Lucia
Rossi, Emanuela
Tinessa, Vincenza
Mosconi, Anna Maria
Nuzzo, Francesco
Di Rella, Francesca
Gravina, Adriano
Iodice, Giovanni
Landi, Gabriella
Pacilio, Carmen
Forestieri, Valeria
Lauria, Rossella
Fabbri, Agnese
Ibrahim, Toni
De Maio, Ermelinda
Barni, Sandro
Gori, Stefania
Simeon, Vittorio
Arenare, Laura
Daniele, Gennaro
Piccirillo, Maria Carmela
Normanno, Nicola
de Matteis, Andrea
Gallo, Ciro
[J]. EUROPEAN JOURNAL OF CANCER, 2019, 118 : 178 - 186
[53] Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
Pfeiler, Georg
Koenigsberg, Robert
Fesl, Christian
Mlineritsch, Brigitte
Stoeger, Herbert
Singer, Christian F.
Poestlberger, Sabine
Steger, Guenther G.
Seifert, Michael
Dubsky, Peter
Taucher, Susanne
Samonigg, Hellmut
Bjelic-Radisic, Vesna
Greil, Richard
Marth, Christian
Gnant, Michael
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2653 - 2659
[54] Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT
Regan, M. M.
Walley, B. A.
Francis, P. A.
Fleming, G. F.
Lang, I.
Gomez, H. L.
Colleoni, M.
Tondini, C.
Pinotti, G.
Salim, M.
Spazzapan, S.
Parmar, V.
Ruhstaller, T.
Abdi, E. A.
Gelber, R. D.
Coates, A. S.
Goldhirsch, A.
Pagani, O.
[J]. ANNALS OF ONCOLOGY, 2017, 28 (09) : 2225 - 2232
[55] Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows
Regan, Meredith M.
Fleming, Gini F.
Walley, Barbara
Francis, Prudence A.
Pagani, Olivia
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (11) : 862 - +
[56] Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial
Ribi, Karin
Luo, Weixiu
Bernhard, Jurg
Francis, Prudence A.
Burstein, Harold J.
Ciruelos, Eva
Bellet, Meritxell
Pavesi, Lorenzo
Lluch, Ana
Visini, Marilena
Parmar, Vani
Tondini, Carlo
Kerbrat, Pierre
Perello, Antonia
Neven, Patrick
Torres, Roberto
Lombardi, Davide
Puglisi, Fabio
Karlsson, Per
Ruhstaller, Thomas
Colleoni, Marco
Coates, Alan S.
Goldhirsch, Aron
Price, Karen N.
Gelber, Richard D.
Regan, Meredith M.
Fleming, Gini F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : 1601 - U122
[57] Endocrine effects of adjuvant letrozole plus triptorelin compared with tamoxifen plus triptorelin in premenopausal patients with early breast cancer
Rossi, Emanuela
Morabito, Alessandro
De Maio, Ermelinda
Di Rella, Francesca
Esposito, Giuseppe
Gravina, Adriano
Labonia, Vincenzo
Landi, Gabriella
Nuzzo, Francesco
Pacilio, Carmen
Piccirillo, Maria Carmela
D'Aiuto, Giuseppe
D'Aiuto, Massimiliano
Rinaldo, Massimo
Botti, Gerardo
Gallo, Ciro
Perrone, Francesco
De Matteis, Andrea
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 264 - 270
[58] Extended Therapy With Letrozole and Ovarian Suppression in Premenopausal Patients With Breast Cancer After Tamoxifen
Ruddy, Kathryn J.
DeSantis, Stephen D.
Barry, William
Guo, Hao
Block, Caroline C.
Borges, Virginia
Winer, Eric P.
Partridge, Ann H.
[J]. CLINICAL BREAST CANCER, 2014, 14 (06) : 413 - 416
[59] Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer
Ruddy, Kathryn J.
Gelber, Shari I.
Tamimi, Rulla M.
Ginsburg, Elizabeth S.
Schapira, Lidia
Come, Steven E.
Borges, Virginia F.
Meyer, Meghan E.
Partridge, Ann H.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) : 1151 - 1156
[60] Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers
Ruggeri, M.
Pagan, E.
Bagnardi, V
Bianco, N.
Gallerani, E.
Buser, K.
Giordano, M.
Gianni, L.
Rabaglio, M.
Freschi, A.
Cretella, E.
Clerico, M.
Farolfi, A.
Simoncini, E.
Ciccarese, M.
Rauch, D.
Ramello, M.
Glaus, A.
Berardi, R.
Pellanda, A. Franzetti
Ribi, K.
Gelber, S.
Partridge, A. H.
Goldhirsch, A.
Pagani, O.
[J]. BREAST, 2019, 47 : 85 - 92

← 1 2 3 4 5 6 7 →